ARCHIVES

NIH director; Targets Increases Favor Established Researchers

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

DCPC Board Okays Core Grant Changes On Shared Resources

January 30, 1987

Freshman Congressman Launches Drive for “Adequate” Cancer Research Funding

August 5, 1983

BCDDP “Major Accomplishment” Described By ACS’ Holleb

July 21, 1978

Clinical Trials Approved By NCI

November 26, 2010